Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

BGM0504

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects

BrightGene Bio-Medical Technology Co · Phase 1 · Completed · Enrollment 80

NCT07166081

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Cohort 1n/rn/rn/rn/r
Cohort 2n/rn/rn/rn/r
Cohort 3n/rn/rn/rn/r
Placebon/rn/rn/rn/r
Cohort 4n/rn/rn/rn/r

Not shown

  • Cohort 1: endpoint not reported
  • Cohort 2: endpoint not reported
  • Cohort 3: endpoint not reported
  • Placebo: endpoint not reported
  • Cohort 4: endpoint not reported